Klebsiella pneumoniae: Going on the offense with a strong defense

Microbiology and Molecular Biology Reviews

Volumn 80, Issue 3, 2016, Pages 629-661

  Paczosa, Michelle K ^a   Mecsas, Joan ^b  

^a Sackler School of Biomedical Sciences   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; BACTERIUM LIPOPOLYSACCHARIDE; HOST FACTOR; INTERLEUKIN 17; OUTER MEMBRANE PROTEIN; PORIN; SIDEROPHORE; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; LIPOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL CAPSULE; BACTERIAL GROWTH; BACTERIAL STRAIN; COMMUNITY ACQUIRED PNEUMONIA; FIMBRIA; GENETIC SCREENING; HOSPITAL ACQUIRED PNEUMONIA; HOST RESISTANCE; HUMAN; IMMUNITY; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LIVER ABSCESS; MENINGITIS; METABOLISM; NONHUMAN; PATIENT RISK; PNEUMONIA; PROTEIN FUNCTION; PROTEIN METABOLISM; PYOGENIC LIVER ABSCESS; REVIEW; TRANSCRIPTION REGULATION; URINARY TRACT INFECTION; DRUG EFFECTS; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; KLEBSIELLA INFECTION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PATHOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL CAPSULES; BACTERIAL OUTER MEMBRANE PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FIMBRIAE, BACTERIAL; HUMANS; IMMUNOCOMPROMISED HOST; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; SIDEROPHORES; VIRULENCE FACTORS;

EID: 84991055936     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00078-15     Document Type: Review

References (375)

1. Friedlander C. 1882. Uber die scizomyceten bei der acuten fibrosen pneumonie. Arch Pathol Anat Physiol Klin Med 87:319-324.
2. Merino S, Camprubi S, Alberti S, Benedi VJ, Tomas JM. 1992. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun 60:2529-2535.
3. Bagley ST. 1985. Habitat association of Klebsiella species. Infect Control 6:52-58.
4. Rock C, Thom KA, Masnick M, Johnson JK, Harris AD, Morgan DJ. 2014. Frequency of Klebsiella pneumoniae carbapenemase (KPC) - producing and non-KPC-producing Klebsiella species contamination of healthcare workers and the environment. Infect Control Hosp Epidemiol 35:426-429. http://dx.doi.org/10.1086/675598.
5. Dao TT, Liebenthal D, Tran TK, Ngoc Thi Vu B, Ngoc Thi Nguyen D, Thi Tran HK, Thi Nguyen CK, Thi Vu HL, Fox A, Horby P, Van Nguyen K, Wertheim HFL. 2014. Klebsiella pneumoniae oropharyngeal carriage in rural and urban Vietnam and the effect of alcohol consumption. PLoS One 9:e91999. http://dx.doi.org/10.1371/journal.pone.0091999.
6. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12. http://dx.doi.org/10.1086/595011.
7. Kuehn BM. 2013. "Nightmare" bacteria on the rise in US hospitals, long-term care facilities. JAMA 309:1573-1574. http://dx.doi.org/10.1001/jama.2013.2922.
8. CDC. 2015. CDC works 24/7 to protect US from health, safety and security threats. CDC, Atlanta, GA.
9. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001.
10. Pitout JD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873-5884. http://dx.doi.org/10.1128/AAC.01019-15.
11. Iredell J, Brown J, Tagg K. 2016. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ 352:h6420. http://dx.doi.org/10.1136/bmj.h6420.
12. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099 (13) 70190-7.
13. CDC. 2013. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62:165-170.
14. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. 2014. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 22:686-696. http://dx.doi.org/10.1016/j.tim.2014.09.003.
15. Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. 2014. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5:e01355-14. http://dx.doi.org/10.1128/mBio.01355-14.
16. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. 2010. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 16:1349-1356. http://dx.doi.org/10.3201/eid1609.091389.
17. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN. 2014. Molecular dissection of the evolution of carbapenemresistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A 111:4988-4993. http://dx.doi.org/10.1073/pnas.1321364111.
18. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P. 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. http://dx.doi.org/10.1371/journal.pone.0004982.
19. Adler A, Khabra E, Chmelnitsky I, Giakkoupi P, Vatopoulos A, Mathers AJ, Yeh AJ, Sifri CD, De Angelis G, Tacconelli E, Villegas MV, Quinn J, Carmeli Y. 2014. Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. Diagn Microbiol Infect Dis 78:12-15. http://dx.doi.org/10.1016/j.diagmicrobio.2013.10.003.
20. Chmelnitsky I, Shklyar M, Hermesh O, Navon-Venezia S, Edgar R, Carmeli Y. 2013. Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258. J Antimicrob Chemother 68:74-83. http://dx.doi.org/10.1093/jac/dks370.
21. Tzouvelekis LS, Miriagou V, Kotsakis SD, Spyridopoulou K, Athanasiou E, Karagouni E, Tzelepi E, Daikos GL. 2013. KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen. Antimicrob Agents Chemother 57:5144-5146. http://dx.doi.org/10.1128/AAC.01052-13.
22. 2+ monocytes to pulmonary clearance of different Klebsiella pneumoniae strains. Infect Immun http://dx.doi.org/10.1128/IAI.00678-15.
23. Chiang TT, Yang YS, Yeh KM, Chiu SK, Wang NC, Lin TY, Huang LY, Chang FY, Siu LK, Lin JC, Chen JH. 2016. Quantification and comparison of virulence and characteristics of different variants of carbapenemaseproducing Klebsiella pneumoniae clinical isolates from Taiwan and the United States. J Microbiol Immunol Infect 49:83-90. http://dx.doi.org/10.1016/j.jmii.2015.08.011.
24. Kobayashi SD, Porter AR, Dorward DW, Brinkworth AJ, Chen L, Kreiswirth BN, DeLeo FR. 14 January 2016. Phagocytosis and killing of carbapenem-resistant ST258 Klebsiella pneumoniae by human neutrophils. J Infect Dis http://dx.doi.org/10.1093/infdis/jiw001.
25. Boyle DP, Zembower TR. 2015. Epidemiology and management of emerging drug-resistant Gram-negative bacteria: extended-spectrum beta-lactamases and beyond. Urol Clin North Am 42:493-505. http://dx.doi.org/10.1016/j.ucl.2015.05.005.
26. Wang D, Chen J, Yang L, Mou Y, Yang Y. 2014. Phenotypic and enzymatic comparative analysis of the KPC variants, KPC-2 and its recently discovered variant KPC-15. PLoS One 9:e111491. http://dx.doi.org/10.1371/journal.pone.0111491.
27. Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228-236. http://dx.doi.org/10.1016/S1473-3099 (09) 70054-4.
28. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51:1553-1555. http://dx.doi.org/10.1128/AAC.01405-06.
29. Cuzon G, Naas T, Correa A, Quinn JP, Villegas MV, Nordmann P. 2013. Dissemination of the KPC-2 carbapenemase in non-Klebsiella pneumoniae enterobacterial isolates from Colombia. Int J Antimicrob Agents 42:59-62. http://dx.doi.org/10.1016/j.ijantimicag.2013.04.002.
30. Cuzon G, Naas T, Villegas MV, Correa A, Quinn JP, Nordmann P. 2011. Wide dissemination of Pseudomonas aeruginosa producing betalactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 55:5350-5353. http://dx.doi.org/10.1128/AAC.00297-11.
31. Cuzon G, Naas T, Guibert M, Nordmann P. 2010. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extendedspectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. Int J Antimicrob Agents 35:265-268. http://dx.doi.org/10.1016/j.ijantimicag.2009.10.021.
32. Tsay RW, Siu LK, Fung CP, Chang FY. 2002. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 162:1021-1027. http://dx.doi.org/10.1001/archinte.162.9.1021.
33. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. 2009. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 122:866-873. http://dx.doi.org/10.1016/j.amjmed.2009.03.034.
34. Korvick JA, Hackett AK, Yu VL, Muder RR. 1991. Klebsiella pneumonia in the modern era: clinicoradiographic correlations. South Med J 84:200-204. http://dx.doi.org/10.1097/00007611-199102000-00012.
35. Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. 1991. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 151:1557-1559.
36. Liu YC, Cheng DL, Lin CL. 1986. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146:1913-1916. http://dx.doi.org/10.1001/archinte.1986.00360220057011.
37. Patel PK, Russo TA, Karchmer AW. 2014. Hypervirulent Klebsiella pneumoniae. Open Forum Infect Dis 1: ofu028. http://dx.doi.org/10.1093/ofid/ofu028.
38. Shon AS, Bajwa RP, Russo TA. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4:107-118. http://dx.doi.org/10.4161/viru.22718.
39. Nadasy KA, Domiati-Saad R, Tribble MA. 2007. Invasive Klebsiella pneumoniae syndrome in North America. Clin Infect Dis 45:e25-e28. http://dx.doi.org/10.1086/519424.
40. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA. 2003. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother 47:3554-3560. http://dx.doi.org/10.1128/AAC.47.11.3554-3560.2003.
41. Yu WL, Ko WC, Cheng KC, Lee HC, Ke DS, Lee CC, Fung CP, Chuang YC. 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis 42:1351-1358. http://dx.doi.org/10.1086/503420.
42. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8:160-166. http://dx.doi.org/10.3201/eid0802.010025.
43. Yang PC, Luh KT, Lee YC, Chang DB, Yu CJ, Wu HD, Lee LN, Kuo SH. 1991. Lung abscesses: US examination and US-guided transthoracic aspiration. Radiology 180:171-175. http://dx.doi.org/10.1148/radiology.180.1.2052687.
44. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. 2005. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis 40:915-922. http://dx.doi.org/10.1086/428574.
45. Zhang Y, Zeng J, Liu W, Zhao F, Hu Z, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Cao B, Wang H. 21 August 2015. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect http://dx.doi.org/10.1016/j.jinf.2015.07.010.
46. Su SC, Siu LK, Ma L, Yeh KM, Fung CP, Lin JC, Chang FY. 2008. Community-acquired liver abscess caused by serotype K1 Klebsiella pneumoniae with CTX-M-15-type extended-spectrum beta-lactamase. Antimicrob Agents Chemother 52:804-805. http://dx.doi.org/10.1128/AAC.01269-07.
47. Li W, Sun G, Yu Y, Li N, Chen M, Jin R, Jiao Y, Wu H. 2014. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis 58:225-232. http://dx.doi.org/10.1093/cid/cit675.
48. Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP. 2011. Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence. PLoS One 6:e26734. http://dx.doi.org/10.1371/journal.pone.0026734.
49. Russo TA, Olson R, Macdonald U, Metzger D, Maltese LM, Drake EJ, Gulick AM. 2014. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun 82:2356-2367. http://dx.doi.org/10.1128/IAI.01667-13.
50. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. 2014. Multistate pointprevalence survey of health care-associated infections. N Engl J Med 370:1198-1208. http://dx.doi.org/10.1056/NEJMoa1306801.
51. Kang C-I, Kim S-H, Bang J-W, Kim H-B, Kim N-J, Kim E-C, Oh M-D, Choe K-W. 2006. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 21:816-822. http://dx.doi.org/10.3346/jkms.2006.21.5.816.
52. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM, Doi Y. 2012. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56:2108-2113. http://dx.doi.org/10.1128/AAC.06268-11.
53. Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A, Themeli-Digalaki K, Tsakris A. 2011. Predictors of mortality in patients with bloodstream infections caused by KPCproducing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17:1798-1803. http://dx.doi.org/10.1111/j.1469-0691.2011.03514.x.
54. Bassi GL, Ferrer M, Torres A. 2011. Nosocomial pneumonia, p 464-480. In Vincent J-L, Abraham E, Moore FA, Kochanek PM, Fink MP (ed), Textbook of critical care, 6th ed. Elsevier Saunders, Philadelphia, PA.
55. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG. 2008. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 19:19-53.
56. Pingleton SK, Fagon JY, Leeper KV, Jr. 1992. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 102:553s-556s.
57. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. 1993. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281-288. http://dx.doi.org/10.1016/0002-9343 (93) 90060-3.
58. Restrepo MI, Peterson J, Fernandez JF, Qin Z, Fisher AC, Nicholson SC. 2013. Comparison of the bacterial etiology of early-onset and lateonset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care 58:1220-1225. http://dx.doi.org/10.4187/respcare.02173.
59. Lee MS, Walker V, Chen LF, Sexton DJ, Anderson DJ. 2013. The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study. Infect Control Hosp Epidemiol 34:657-662. http://dx.doi.org/10.1086/670991.
60. Jones RN. 2010. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 51:S81-S87. http://dx.doi.org/10.1086/653053.
61. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Genin R, Yvin JL. 2004. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24:779-785. http://dx.doi.org/10.1183/09031936.04.00119503.
62. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, Yeom JS, Kim CK, Kim SW, Chang HH, Kim YS, Jung SI, Tong Z, Wang Q, Huang SG, Liu JW, Lalitha MK, Tan BH, Van PH, Carlos CC, So T. 2008. Epidemiology and clinical outcomes of communityacquired pneumonia in adult patients in Asian countries: a prospective study by the Asian Network for Surveillance of Resistant Pathogens. Int J Antimicrob Agents 31:107-114. http://dx.doi.org/10.1016/j.ijantimicag.2007.09.014.
63. Kawai S, Ochi M, Nakagawa T, Goto H. 2004. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan. J Infect Chemother 10:352-358. http://dx.doi.org/10.1007/s10156-004-0350-2.
64. Feldman C, Ross S, Mahomed AG, Omar J, Smith C. 1995. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 89:187-192. http://dx.doi.org/10.1016/0954-6111 (95) 90246-5.
65. Lin YT, Jeng YY, Chen TL, Fung CP. 2010. Bacteremic communityacquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis 10:307. http://dx.doi.org/10.1186/1471-2334-10-307.
66. Hu HC, Huang CC, Tsai YH, Lee CH, Hsieh MJ. 2005. Outcome analysis of patients requiring mechanical ventilation with severe communityacquired pneumonia and identified bacterial pathogens. Chang Gung Med J 28:229-236.
67. Blue DE, Allen SD. 2011. Microbiology for the surgical pathologist, p 315-406. In Cheng L, Bostwick GD (ed), Essentials of anatomic pathology. Springer, New York, NY. http://dx.doi.org/10.1007/978-1-4419-6043-6-6.
68. Moon WK, Im JG, Yeon KM, Han MC. 1995. Complications of Klebsiella pneumonia: CT evaluation. J Comput Assist Tomogr 19:176-181. http://dx.doi.org/10.1097/00004728-199503000-00002.
69. Czaja CA, Scholes D, Hooton TM, Stamm WE. 2007. Populationbased epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 45:273-280. http://dx.doi.org/10.1086/519268.
70. Echols RM, Tosiello RL, Haverstock DC, Tice AD. 1999. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis 29:113-119. http://dx.doi.org/10.1086/520138.
71. Lorente Garin JA, Placer Santos J, Salvado Costa M, Segura Alvarez C, Gelabert-Mas A. 2005. Antibiotic resistance transformation in communityacquired urinary infections. Rev Clin Esp 205:259-264. (In Spanish.) http://dx.doi.org/10.1157/13076148.
72. Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. 2007. Community-onset urinary tract infections: a population-based assessment. Infection 35:150-153. http://dx.doi.org/10.1007/s15010-007-6180-2.
73. Linhares I, Raposo T, Rodrigues A, Almeida A. 2013. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 13:19. http://dx.doi.org/10.1186/1471-2334-13-19.
74. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz De Alba P, Pascual A. 2008. Faecal carriage of extended-spectrum beta-lactamaseproducing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 62:1142-1149. http://dx.doi.org/10.1093/jac/dkn293.
75. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21:26-59. http://dx.doi.org/10.1128/CMR.00019-07.
76. Wu YH, Chen PL, Hung YP, Ko WC. 2014. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect 47:197-203. http://dx.doi.org/10.1016/j.jmii.2012.09.001.
77. Tsai SS, Huang JC, Chen ST, Sun JH, Wang CC, Lin SF, Hsu BR, Lin JD, Huang SY, Huang YY. 2010. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients. Chang Gung Med J 33:532-539.
78. Ortega M, Marco F, Soriano A, Almela M, Martinez JA, Pitart C, Mensa J. 2013. Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010. J Infect 67:282-287. http://dx.doi.org/10.1016/j.jinf.2013.06.003.
79. Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589-603.
80. Chetcuti Zammit S, Azzopardi N, Sant J. 2014. Mortality risk score for Klebsiella pneumoniae bacteraemia. Eur J Intern Med 25:571-576. http://dx.doi.org/10.1016/j.ejim.2014.04.008.
81. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG, Filho JR, Edmond MB, Pereira CA. 2006. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 6:24. http://dx.doi.org/10.1186/1471-2334-6-24.
82. Mosqueda-Gomez JL, Montano-Loza A, Rolon AL, Cervantes C, Bobadilladel-Valle JM, Silva-Sanchez J, Garza-Ramos U, Villasis-Keever A, Galindo-Fraga A, Palacios GM, Ponce-De-Leon A, Sifuentes-Osornio J. 2008. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae. A case-control study. Int J Infect Dis 12:653-659. http://dx.doi.org/10.1016/j.ijid.2008.03.008.
83. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Ariza J, Gudiol F. 2001. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect 47:53-59. http://dx.doi.org/10.1053/jhin. 2000.0862.
84. Jong GM, Hsiue TR, Chen CR, Chang HY, Chen CW. 1995. Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 107:214-217. http://dx.doi.org/10.1378/chest.107.1.214.
85. Bilinski J, Grzesiowski P, Muszynski J, Wroblewska M, Madry K, Robak K, Dzieciatkowski T, Wiktor-Jedrzejczak W, Basak GW. 9 March 2016. Fecal microbiota transplantation inhibits multidrugresistant gut pathogens: preliminary report performed in an immunocompromised host. Arch Immunol Ther Exp (Warsz) http://dx.doi.org/10.1007/s00005-016-0387-9.
86. Lagier JC, Million M, Fournier PE, Brouqui P, Raoult D. 2015. Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemaseproducing Klebsiella pneumoniae. J Hosp Infect 90:173-174. http://dx.doi.org/10.1016/j.jhin. 2015.02.013.
87. Kim JK, Chung DR, Wie SH, Yoo JH, Park SW. 2009. Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 28:109-111. http://dx.doi.org/10.1007/s10096-008-0595-2.
88. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wang JH, Wann SR, Lin HH. 1998. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434-1438. http://dx.doi.org/10.1086/516369.
89. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. 2007. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45:284-293. http://dx.doi.org/10.1086/519262.
90. Li B, Zhao Y, Liu C, Chen Z, Zhou D. 2014. Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol 9:1071-1081. http://dx.doi.org/10.2217/fmb.14.48.
91. Keller JJ, Tsai MC, Lin CC, Lin YC, Lin HC. 2013. Risk of infections subsequent to pyogenic liver abscess: a nationwide population-based study. Clin Microbiol Infect 19:717-722. http://dx.doi.org/10.1111/1469-0691.12027.
92. Tsai MH, Lu CH, Huang CR, Chuang YC, Tsai NW, Tsai HH, Chen SF, Li CS, Chang HW, Chien CC, Chang WN. 2006. Bacterial meningitis in young adults in southern Taiwan: clinical characteristics and therapeutic outcomes. Infection 34:2-8. http://dx.doi.org/10.1007/s15010-006-4144-6.
93. Lu CH, Chang WN, Chuang YC, Chang HW. 1999. Gram-negative bacillary meningitis in adult post-neurosurgical patients. Surg Neurol 52:438-443, discussion 443-434. http://dx.doi.org/10.1016/S0090-3019 (99) 00129-9.
94. Huang TT, Tseng FY, Liu TC, Hsu CJ, Chen YS. 2005. Deep neck infection in diabetic patients: comparison of clinical picture and outcomes with nondiabetic patients. Otolaryngol Head Neck Surg 132:943-947. http://dx.doi.org/10.1016/j.otohns.2005.01.035.
95. Cheng NC, Tai HC, Chang SC, Chang CH, Lai HS. 2015. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis 15:417. http://dx.doi.org/10.1186/s12879-015-1144-0.
96. Scheld WM. 1991. Developments in the pathogenesis, diagnosis and treatment of nosocomial pneumonia. Surg Gynecol Obstet 172(Suppl):42-53.
97. Hu X, Lee JS, Pianosi PT, Ryu JH. 2015. Aspiration-related pulmonary syndromes. Chest 147:815-823. http://dx.doi.org/10.1378/chest.14-1049.
98. Wunderink RG, Waterer GW. 2004. Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. Infect Dis Clin North Am 18:743-759. http://dx.doi.org/10.1016/j.idc.2004.07.004.
99. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Jr, Musher DM, Niederman MS, Torres A, Whitney CG. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72. http://dx.doi.org/10.1086/511159.
100. Rammaert B, Goyet S, Beaute J, Hem S, Te V, Try PL, Mayaud C, Borand L, Buchy P, Guillard B, Vong S. 2012. Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment. BMC Infect Dis 12:3. http://dx.doi.org/10.1186/1471-2334-12-3.
101. Song JH, Thamlikitkul V, Hsueh PR. 2011. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents 38:108-117. http://dx.doi.org/10.1016/j.ijantimicag.2011.02.017.
102. Saibal MA, Rahman SH, Nishat L, Sikder NH, Begum SA, Islam MJ, Uddin KN. 2012. Community acquired pneumonia in diabetic and nondiabetic hospitalized patients: presentation, causative pathogens and outcome. Bangladesh Med Res Counc Bull 38:98-103.
103. Zhang P, Nelson S, Summer WR, Spitzer JA. 1997. Acute ethanol intoxication suppresses the pulmonary inflammatory response in rats challenged with intrapulmonary endotoxin. Alcohol Clin Exp Res 21:773-778. http://dx.doi.org/10.1111/j.1530-0277.1997.tb03838.x.
104. Quinton LJ, Nelson S, Zhang P, Happel KI, Gamble L, Bagby GJ. 2005. Effects of systemic and local CXC chemokine administration on the ethanolinduced suppression of pulmonary neutrophil recruitment. Alcohol Clin Exp Res 29:1198-1205. http://dx.doi.org/10.1097/01. ALC.0000171927.66130. AA.
105. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J. 1991. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 164:901-906. http://dx.doi.org/10.1093/infdis/164.5.901.
106. Happel KI, Odden AR, Zhang P, Shellito JE, Bagby GJ, Nelson S. 2006. Acute alcohol intoxication suppresses the interleukin 23 response to Klebsiella pneumoniae infection. Alcohol Clin Exp Res 30:1200-1207. http://dx.doi.org/10.1111/j.1530-0277.2006.00144.x.
107. Szabo G, Verma B, Catalano D. 1993. Selective inhibition of antigenspecific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production. J Leukoc Biol 54:534-544.
108. Higdon ML, Higdon JA. 2006. Treatment of oncologic emergencies. Am Fam Physician 74:1873-1880.
109. Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, Sannomiya P. 2007. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 40:1037-1044. http://dx.doi.org/10.1590/S0100-879X2006005000143.
110. Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. 2015. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144:171-185. http://dx.doi.org/10.1111/imm.12394.
111. Collado MC, Cernada M, Neu J, Perez-Martinez G, Gormaz M, Vento M. 2015. Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatr Res 77:726-731. http://dx.doi.org/10.1038/pr.2015.54.
112. Afroza S. 2006. Neonatal sepsis-a global problem: an overview. Mymensingh Med J 15:108-114.
113. Boyd AR, Orihuela CJ. 2011. Dysregulated inflammation as a risk factor for pneumonia in the elderly. Aging Dis 2:487-500.
114. Jeong SJ, Yoon SS, Han SH, Yong DE, Kim CO, Kim JM. 2014. Evaluation of humoral immune response to nosocomial pathogen and functional status in elderly patients with sepsis. Arch Gerontol Geriatr 58:10-14. http://dx.doi.org/10.1016/j.archger.2013.07.001.
115. Teramoto S, Yoshida K, Hizawa N. 2015. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig 53:178-184. http://dx.doi.org/10.1016/j.resinv. 2015.01.003.
116. Struve C, Bojer M, Krogfelt KA. 2008. Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect Immun 76:4055-4065. http://dx.doi.org/10.1128/IAI.00494-08.
117. Rosen DA, Pinkner JS, Walker JN, Elam JS, Jones JM, Hultgren SJ. 2008. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect Immun 76:3346-3356. http://dx.doi.org/10.1128/IAI.00340-08.
118. Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PM, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ. 2015. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013. JAMA 314:1479-1487. http://dx.doi.org/10.1001/jama.2015.12480.
119. Mishra SK, Basukala P, Basukala O, Parajuli K, Pokhrel BM, Rijal BP. 2015. Detection of biofilm production and antibiotic resistance pattern in clinical isolates from indwelling medical devices. Curr Microbiol 70:128-134. http://dx.doi.org/10.1007/s00284-014-0694-5.
120. Zolfaghari PS, Wyncoll DL. 2011. The tracheal tube: gateway to ventilatorassociated pneumonia. Crit Care 15:310. http://dx.doi.org/10.1186/cc10352.
121. Chatterjee S, Maiti P, Dey R, Kundu A, Dey R. 2014. Biofilms on indwelling urologic devices: microbes and antimicrobial management prospect. Ann Med Health Sci Res 4:100-104. http://dx.doi.org/10.4103/2141-9248.126612.
122. Fung CP, Lin YT, Lin JC, Chen TL, Yeh KM, Chang FY, Chuang HC, Wu HS, Tseng CP, Siu LK. 2012. Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess. Emerg Infect Dis 18:1322-1325. http://dx.doi.org/10.3201/eid1808.111053.
123. Gupta A. 2002. Hospital-acquired infections in the neonatal intensive care unit-Klebsiella pneumoniae. Semin Perinatol 26:340-345. http://dx.doi.org/10.1053/sper.2002.36267.
124. Papakonstantinou I, Angelopoulos E, Baraboutis I, Perivolioti E, Parisi M, Psaroudaki Z, Kampisiouli E, Argyropoulou A, Nanas S, Routsi C. 2015. Risk factors for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens in mechanically ventilated ICU patients. J Chemother 27:283-289. http://dx.doi.org/10.1179/1973947814Y.0000000199.
125. Haverkorn ML, Michel MF. 1979. Nosocomial klebsiellas. I. Colonization of hospitalized patients. J Hyg (Lond) 82:177-193.
126. Taur Y, Pamer EG. 2013. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 26:332-337. http://dx.doi.org/10.1097/QCO.0b013e3283630dd3.
127. Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. 1971. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med 74:657-664. http://dx.doi.org/10.7326/0003-4819-74-5-657.
128. Nguyen ML, Toye B, Kanji S, Zvonar R. 2015. Risk factors for and outcomes of bacteremia caused by extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella species at a Canadian tertiary care hospital. Can J Hosp Pharm 68:136-143.
129. Gagliotti C, Giordani S, Ciccarese V, Barozzi A, Giovinazzi A, Pietrantonio AM, Moro ML, Pinelli G, Sarti M. 2014. Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study. Am J Infect Control 42:1006-1008. http://dx.doi.org/10.1016/j.ajic.2014.05.028.
130. Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, Vamvakopoulou S, Filos KS, Anastassiou ED. 2014. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis 46:642-648. http://dx.doi.org/10.3109/00365548.2014.923106.
131. Kaspar T, Schweiger A, Droz S, Marschall J. 2015. Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened? Antimicrob Resist Infect Control 4:31. http://dx.doi.org/10.1186/s13756-015-0071-6.
132. Zhang P, Summer WR, Bagby GJ, Nelson S. 2000. Innate immunity and pulmonary host defense. Immunol Rev 173:39-51. http://dx.doi.org/10.1034/j.1600-065X.2000.917306.x.
133. Lee CH, Chang CC, Liu JW, Chen RF, Yang KD. 2014. Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis. Virulence 5:673-679. http://dx.doi.org/10.4161/viru.32076.
134. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis LA, Grue RM, Schlepper-Schafer J, Ezekowitz AR, Ohman DE, Ofek I. 1995. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun 63:847-852.
135. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaeffer J, Ofek I. 1997. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 272:L344-L352.
136. Puente JL, Finlay BB. 2001. Pathogenic Escherichia coli, p 387-456. In Groisman EA (ed), Principles of bacterial pathogenesis. Academic Press, San Diego, CA. http://dx.doi.org/10.1016/B978-012304220-0/50010-8.
137. McClane BA, Mietzner TA. 1999. Overcoming the physical and chemical defenses of the human body, p 225-226. In McClane BA, Mietzner TA, Dowling JN, Phillips BA (ed), Microbial pathogenesis. Hayes Barton Press, Raleigh, NC.
138. Ganz T. 2002. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 109:693-697. http://dx.doi.org/10.1172/JCI0215218.
139. Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. 2015. Complement system part II: role in immunity. Front Immunol 6:257. http://dx.doi.org/10.3389/fimmu.2015.00257.
140. Murphy K, Travers P, Walport M, Janeway C. 2012. Janeway's immunobiology, 8th ed. Garland Science, New York, NY.
141. Coya JM, Akinbi HT, Saenz A, Yang L, Weaver TE, Casals C. 2015. Natural anti-infective pulmonary proteins: in vivo cooperative action of surfactant protein SP-A and the lung antimicrobial peptide SP-BN. J Immunol 195:1628-1636. http://dx.doi.org/10.4049/jimmunol.1500778.
142. Gross GN, Rehm SR, Pierce AK. 1978. The effect of complement depletion on lung clearance of bacteria. J Clin Invest 62:373-378. http://dx.doi.org/10.1172/JCI109138.
143. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72:7107-7114. http://dx.doi.org/10.1128/IAI.72.12.7107-7114.2004.
144. Albertí S, Alvarez D, Merino S, Casado MT, Vivanco F, Tomás JM, Benedí VJ. 1996. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae. Infect Immun 64:4726-4732.
145. Alberti S, Marques G, Camprubi S, Merino S, Tomas JM, Vivanco F, Benedi VJ. 1993. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 61:852-860.
146. Álvarez D, Merino S, Tomás JM, Benedí VJ, Albertí S. 2000. Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect Immun 68:953-955. http://dx.doi.org/10.1128/IAI.68.2.953-955.2000.
147. Ciurana B, Tomas JM. 1987. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun 55:2741-2746.
148. Tomas JM, Benedi VJ, Ciurana B, Jofre J. 1986. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 54:85-89.
149. Moranta D, Regueiro V, March C, Llobet E, Margareto J, Larrarte E, Garmendia J, Bengoechea JA. 2010. Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells. Infect Immun 78:1135-1146. http://dx.doi.org/10.1128/IAI.00940-09.
150. Kostina E, Ofek I, Crouch E, Friedman R, Sirota L, Klinger G, Sahly H, Keisari Y. 2005. Noncapsulated Klebsiella pneumoniae bearing mannosecontaining O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. Infect Immun 73:8282-8290. http://dx.doi.org/10.1128/IAI.73.12.8282-8290.2005.
151. Sahly H, Schubert S, Harder J, Kleine M, Sandvang D, Ullmann U, Schroder JM, Podschun R. 2006. Activity of human beta-defensins 2 and 3 against ESBL-producing Klebsiella strains. J Antimicrob Chemother 57:562-565. http://dx.doi.org/10.1093/jac/dkl003.
152. Clements A, Tull D, Jenney AW, Farn JL, Kim SH, Bishop RE, McPhee JB, Hancock RE, Hartland EL, Pearse MJ, Wijburg OL, Jackson DC, McConville MJ, Strugnell RA. 2007. Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem 282:15569-15577. http://dx.doi.org/10.1074/jbc. M701454200.
153. Broug-Holub E, Toews GB, Van Iwaarden JF, Strieter RM, Kunkel SL, Paine R, III, Standiford TJ. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun 65:1139-1146.
154. Kumar V, Sharma A. 2010. Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 10:1325-1334. http://dx.doi.org/10.1016/j.intimp. 2010.08.012.
155. Batra S, Cai S, Balamayooran G, Jeyaseelan S. 2012. Intrapulmonary administration of leukotriene B (4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. J Immunol 188:3458-3468. http://dx.doi.org/10.4049/jimmunol.1101985.
156. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE, Kolls JK. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25:335-340. http://dx.doi.org/10.1165/ajrcmb.25.3.4424.
157. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 4:615-618. http://dx.doi.org/10.1038/nm0598-615.
158. Hirche TO, Gaut JP, Heinecke JW, Belaaouaj A. 2005. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol 174:1557-1565. http://dx.doi.org/10.4049/jimmunol.174.3.1557.
159. Greenberg SS, Ouyang J, Zhao X, Parrish C, Nelson S, Giles TD. 1999. Effects of ethanol on neutrophil recruitment and lung host defense in nitric oxide synthase I and nitric oxide synthase II knockout mice. Alcohol Clin Exp Res 23:1435-1445. http://dx.doi.org/10.1111/j.1530-0277.1999.tb04664.x.
160. Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, Papayannopoulos V. 2014. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15:1017-1025. http://dx.doi.org/10.1038/ni.2987.
161. Sharma A, Steichen AL, Jondle CN, Mishra BB, Sharma J. 2014. Protective role of Mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and extracellular trap formation. J Infect Dis 209:1837-1846. http://dx.doi.org/10.1093/infdis/jit820.
162. Barletta KE, Cagnina RE, Burdick MD, Linden J, Mehrad B. 2012. Adenosine A (2B) receptor deficiency promotes host defenses against gram-negative bacterial pneumonia. Am J Respir Crit Care Med 186:1044-1050. http://dx.doi.org/10.1164/rccm.201204-0622OC.
163. Achouiti A, Vogl T, Urban CF, Rohm M, Hommes TJ, Van Zoelen MA, Florquin S, Roth J, Van't Veer C, De Vos AF, Van Der Poll T. 2012. Myeloid-related protein-14 contributes to protective immunity in gramnegative pneumonia derived sepsis. PLoS Pathog 8:e1002987. http://dx.doi.org/10.1371/journal.ppat.1002987.
164. Ariffin H, Navaratnam P, Lin HP. 2002. Surveillance study of bacteraemic episodes in febrile neutropenic children. Int J Clin Pract 56:237-240.
165. Vento S, Cainelli F. 2003. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4:595-604. http://dx.doi.org/10.1016/S1470-2045 (03) 01218-X.
166. Velasco E, Byington R, Martins CA, Schirmer M, Dias LM, Goncalves VM. 2006. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 25:1-7. http://dx.doi.org/10.1007/s10096-005-0077-8.
167. Lawlor MS, Hsu J, Rick PD, Miller VL. 2005. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58:1054-1073. http://dx.doi.org/10.1111/j.1365-2958.2005.04918.x.
168. Lau HY, Clegg S, Moore TA. 2007. Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia. Microb Pathog 42:148-155. http://dx.doi.org/10.1016/j.micpath.2007.01.001.
169. Tsai WC, Strieter RM, Wilkowski JM, Bucknell KA, Burdick MD, Lira SA, Standiford TJ. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 161:2435-2440.
170. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. 2009. Both TRIFand MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol 183:6629-6638. http://dx.doi.org/10.4049/jimmunol.0901033.
171. Chen L, Zhang Z, Barletta KE, Burdick MD, Mehrad B. 2013. Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors. Am J Physiol Lung Cell Mol Physiol 305:L702-L711. http://dx.doi.org/10.1152/ajplung.00194.2013.
172. Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, McMillan TR, Krieg AM, Akira S, Standiford TJ. 2007. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol 179:3937-3946. http://dx.doi.org/10.4049/jimmunol.179.6.3937.
173. Schurr JR, Young E, Byrne P, Steele C, Shellito JE, Kolls JK. 2005. Central role of Toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect Immun 73:532-545. http://dx.doi.org/10.1128/IAI.73.1.532-545.2005.
174. Jeyaseelan S, Young SK, Yamamoto M, Arndt PG, Akira S, Kolls JK, Worthen GS. 2006. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa. J Immunol 177:538-547. http://dx.doi.org/10.4049/jimmunol.177.1.538.
175. Van Lieshout MH, Blok DC, Wieland CW, De Vos AF, Van't Veer C, Van Der Poll T. 2012. Differential roles of MyD88 and TRIF in hematopoietic and resident cells during murine gram-negative pneumonia. J Infect Dis 206:1415-1423. http://dx.doi.org/10.1093/infdis/jis505.
176. Wieland CW, Van Lieshout MH, Hoogendijk AJ, Van Der Poll T. 2011. Host defence during Klebsiella pneumonia relies on haematopoieticexpressed Toll-like receptors 4 and 2. Eur Respir J 37:848-857. http://dx.doi.org/10.1183/09031936.00076510.
177. Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, Standiford TJ. 2010. Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PLoS One 5:e9896. http://dx.doi.org/10.1371/journal.pone.0009896.
178. Standiford LR, Standiford TJ, Newstead MJ, Zeng X, Ballinger MN, Kovach MA, Reka AK, Bhan U. 2012. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 302:L447-L454. http://dx.doi.org/10.1152/ajplung.00415.2010.
179. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, Shellito JE, Schurr JR, Bagby GJ, Nelson S, Kolls JK. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 170:4432-4436. http://dx.doi.org/10.4049/jimmunol.170.9.4432.
180. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S, Kolls JK. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202:761-769. http://dx.doi.org/10.1084/jem.20050193.
181. Price AE, Reinhardt RL, Liang HE, Locksley RM. 2012. Marking and quantifying IL-17A-producing cells in vivo. PLoS One 7:e39750. http://dx.doi.org/10.1371/journal.pone.0039750.
182. Cai S, Batra S, Wakamatsu N, Pacher P, Jeyaseelan S. 2012. NLRC4 inflammasome-mediated production of IL-1beta modulates mucosal immunity in the lung against gram-negative bacterial infection. J Immunol 188:5623-5635. http://dx.doi.org/10.4049/jimmunol.1200195.
183. Moore TA, Moore BB, Newstead MW, Standiford TJ. 2000. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 165:2643-2650. http://dx.doi.org/10.4049/jimmunol.165.5.2643.
184. Cogen AL, Moore TA. 2009. Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia. Infect Immun 77:360-366. http://dx.doi.org/10.1128/IAI.00909-08.
185. Moore TA, Perry ML, Getsoian AG, Newstead MW, Standiford TJ. 2002. Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect Immun 70:6310-6318. http://dx.doi.org/10.1128/IAI.70.11.6310-6318.2002.
186. Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Iwakurai Y, Yamaguchi K. 2001. Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines. J Med Microbiol 50:959-964. http://dx.doi.org/10.1099/0022-1317-50-11-959.
187. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14:275-281. http://dx.doi.org/10.1038/nm1710.
188. Zheng M, Horne W, McAleer JP, Pociask D, Eddens T, Good M, Gao B, Kolls JK. 2016. Therapeutic role of interleukin 22 in experimental intra-abdominal Klebsiella pneumoniae infection in mice. Infect Immun 84:782-789. http://dx.doi.org/10.1128/IAI.01268-15.
189. Xu X, Weiss ID, Zhang HH, Singh SP, Wynn TA, Wilson MS, Farber JM. 2014. Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia. J Immunol 192:1778-1786. http://dx.doi.org/10.4049/jimmunol.1300039.
190. Georgel P, Radosavljevic M, Macquin C, Bahram S. 2011. The nonconventionalMHCclass I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol 48:769-775. http://dx.doi.org/10.1016/j.molimm.2010.12.002.
191. Ussher JE, Klenerman P, Willberg CB. 2014. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol 5:450. http://dx.doi.org/10.3389/fimmu.2014.00450.
192. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, Duncan JA, Ting JP. 2009. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol 183:2008-2015. http://dx.doi.org/10.4049/jimmunol.0900138.
193. Webster SJ, Daigneault M, Bewley MA, Preston JA, Marriott HM, Walmsley SR, Read RC, Whyte MK, Dockrell DH. 2010. Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease. J Immunol 185:2968-2979. http://dx.doi.org/10.4049/jimmunol.1000805.
194. Cortes G, Borrell N, De Astorza B, Gomez C, Sauleda J, Alberti S. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70:2583-2590. http://dx.doi.org/10.1128/IAI.70.5.2583-2590.2002.
195. Trosky JE, Liverman AD, Orth K. 2008. Yersinia outer proteins: Yops. Cell Microbiol 10:557-565. http://dx.doi.org/10.1111/j.1462-5822.2007.01109.x.
196. Domenico P, Salo RJ, Cross AS, Cunha BA. 1994. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect Immun 62:4495-4499.
197. Lawlor MS, Handley SA, Miller VL. 2006. Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections. Infect Immun 74:5402-5407. http://dx.doi.org/10.1128/IAI.00244-06.
198. Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Yamaguchi K. 2000. Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae. J Med Microbiol 49:1003-1010. http://dx.doi.org/10.1099/0022-1317-49-11-1003.
199. Fang C-T, Chuang Y-P, Shun C-T, Chang S-C, Wang J-T. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 199:697-705. http://dx.doi.org/10.1084/jem.20030857.
200. Yeh K-M, Kurup A, Siu LK, Koh YL, Fung C-P, Lin J-C, Chen T-L, Chang F-Y, Koh T-H. 2007. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 45:466-471. http://dx.doi.org/10.1128/JCM.01150-06.
201. Pan Y-J, Fang H-C, Yang H-C, Lin T-L, Hsieh P-F, Tsai F-C, Keynan Y, Wang J-T. 2008. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 46:2231-2240. http://dx.doi.org/10.1128/JCM.01716-07.
202. Arakawa Y, Ohta M, Wacharotayankun R, Mori M, Kido N, Ito H, Komatsu T, Sugiyama T, Kato N. 1991. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2). Infect Immun 59:2043-2050.
203. Shu HY, Fung CP, Liu YM, Wu KM, Chen YT, Li LH, Liu TT, Kirby R, Tsai SF. 2009. Genetic diversity of capsular polysaccharide biosynthesis in Klebsiella pneumoniae clinical isolates. Microbiology 155:4170-4183. http://dx.doi.org/10.1099/mic.0.029017-0.
204. Pan Y-J, Lin T-L, Chen Y-H, Hsu C-R, Hsieh P-F, Wu M-C, Wang J-T. 2013. Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One 8:e80670. http://dx.doi.org/10.1371/journal.pone.0080670.
205. Arakawa Y, Wacharotayankun R, Nagatsuka T, Ito H, Kato N, Ohta M. 1995. Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol 177:1788-1796.
206. Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, Decre D. 2013. wzi gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol 51:4073-4078. http://dx.doi.org/10.1128/JCM.01924-13.
207. Diago-Navarro E, Chen L, Passet V, Burack S, Ulacia-Hernando A, Kodiyanplakkal RP, Levi MH, Brisse S, Kreiswirth BN, Fries BC. 2014. Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis 210:803-813. http://dx.doi.org/10.1093/infdis/jiu157.
208. Cubero M, Grau I, Tubau F, Pallares R, Dominguez MA, Linares J, Ardanuy C. 2016. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013). Clin Microbiol Infect 22:154-160. http://dx.doi.org/10.1016/j.cmi.2015.09.025.
209. Park DJ, Yu JK, Park KG, Park YJ. 2015. Genotypes of ciprofloxacinresistant Klebsiella pneumoniae in Korea and their characteristics according to the genetic lineages. Microb Drug Resist 21:622-630. http://dx.doi.org/10.1089/mdr.2015.0001.
210. Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC. 2015. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York City tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 53:2060-2067. http://dx.doi.org/10.1128/JCM.03455-14.
211. Bushell SR, Mainprize IL, Wear MA, Lou H, Whitfield C, Naismith JH. 2013. Wzi is an outer membrane lectin that underpins group 1 capsule assembly in Escherichia coli. Structure 21:844-853. http://dx.doi.org/10.1016/j.str.2013.03.010.
212. Rahn A, Beis K, Naismith JH, Whitfield C. 2003. A novel outer membrane protein, Wzi, is involved in surface assembly of the Escherichia coli K30 group 1 capsule. J Bacteriol 185:5882-5890. http://dx.doi.org/10.1128/JB.185.19.5882-5890.2003.
213. Rahn A, Drummelsmith J, Whitfield C. 1999. Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. J Bacteriol 181:2307-2313.
214. Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT. 2011. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology 157:3446-3457. http://dx.doi.org/10.1099/mic.0.050336-0.
215. Nassif X, Honore N, Vasselon T, Cole ST, Sansonetti PJ. 1989. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae. Mol Microbiol 3:1349-1359. http://dx.doi.org/10.1111/j.1365-2958.1989.tb00116.x.
216. Lai YC, Peng HL, Chang HY. 2003. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J Bacteriol 185:788-800. http://dx.doi.org/10.1128/JB.185.3.788-800.2003.
217. Wacharotayankun R, Arakawa Y, Ohta M, Tanaka K, Akashi T, Mori M, Kato N. 1993. Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun 61:3164-3174.
218. Allen P, Hart CA, Saunders JR. 1987. Isolation from Klebsiella and characterization of two rcs genes that activate colanic acid capsular biosynthesis in Escherichia coli. J Gen Microbiol 133:331-340.
219. Stout V, Torres-Cabassa A, Maurizi MR, Gutnick D, Gottesman S. 1991. RcsA, an unstable positive regulator of capsular polysaccharide synthesis. J Bacteriol 173:1738-1747.
220. Chuang Y-P, Fang C-T, Lai S-Y, Chang S-C, Wang J-T. 2006. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 193:645-654. http://dx.doi.org/10.1086/499968.
221. Struve C, Bojer M, Nielsen EM, Hansen DS, Krogfelt KA. 2005. Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1. J Med Microbiol 54:1111-1113. http://dx.doi.org/10.1099/jmm.0.46165-0.
222. Yeh KM, Chang FY, Fung CP, Lin JC, Siu LK. 2006. magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1. J Med Microbiol 55:803-804. http://dx.doi.org/10.1099/jmm.0.46368-0.
223. Fang C-T, Lai S-Y, Yi W-C, Hsueh P-R, Liu K-L. 2010. The function of wzy-K1 (magA), the serotype K1 polymerase gene in Klebsiella pneumoniae cps gene cluster. J Infect Dis 201:1268-1269. http://dx.doi.org/10.1086/652183.
224. Yu W-L, Fung C-P, Ko W-C, Chuang Y-C. 2007. Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites. J Infect Dis 195:1235-1236. http://dx.doi.org/10.1086/512686.
225. Cryz SJ, Jr, Mortimer PM, Mansfield V, Germanier R. 1986. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 23:687-690.
226. Mizuta K, Ohta M, Mori M, Hasegawa T, Nakashima I, Kato N. 1983. Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun 40:56-61.
227. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62:1-6. http://dx.doi.org/10.1016/j.diagmicrobio.2008.04.007.
228. Sahly H, Aucken H, Benedi VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Sandvang D, Tomas JM, Ullmann U. 2004. Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 23:20-26. http://dx.doi.org/10.1007/s10096-003-1047-7.
229. Lin JC, Chang FY, Fung CP, Xu JZ, Cheng HP, Wang JJ, Huang LY, Siu LK. 2004. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect 6:1191-1198. http://dx.doi.org/10.1016/j.micinf.2004.06.003.
230. Tigyi Z, Gahrs W, Emody L, Makovitzky J. 2009. Topo-optical investigations on the surface of bacterial cells during the phagocytosis of Klebsiella pneumoniae in mouse. Acta Histochem 111:300-307. http://dx.doi.org/10.1016/j.acthis.2008.11.009.
231. Varki A, Schauer R. 2009. Sialic acids, p 199-218. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
232. Athamna A, Ofek I, Keisari Y, Markowitz S, Dutton GG, Sharon N. 1991. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 59:1673-1682.
233. Ofek I, Goldhar J, Keisari Y, Sharon N. 1995. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 49:239-276. http://dx.doi.org/10.1146/annurev. mi.49.100195.001323.
234. Sahly H, Keisari Y, Crouch E, Sharon N, Ofek I. 2008. Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens. Infect Immun 76:1322-1332. http://dx.doi.org/10.1128/IAI.00910-07.
235. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA. 2015. Mapping the evolution of hypervirulent Klebsiella pneumoniae. mBio 6:e00630-15. http://dx.doi.org/10.1128/mBio.00630-15.
236. Luo Y, Wang Y, Ye L, Yang J. 2014. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 20:O818-O824. http://dx.doi.org/10.1111/1469-0691.12664.
237. Chung DR, Lee HR, Lee SS, Kim SW, Chang HH, Jung SI, Oh MD, Ko KS, Kang CI, Peck KR, Song JH. 2008. Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J Clin Microbiol 46:4061-4063. http://dx.doi.org/10.1128/JCM.01577-08.
238. Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, Ip M. 2011. Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol 49:3761-3765. http://dx.doi.org/10.1128/JCM.00977-11.
239. Liao CH, Huang YT, Chang CY, Hsu HS, Hsueh PR. 2014. Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections. Eur J Clin Microbiol Infect Dis 33:365-369. http://dx.doi.org/10.1007/s10096-013-1964-z.
240. Turton JF, Englender H, Gabriel SN, Turton SE, Kaufmann ME, Pitt TL. 2007. Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents. J Med Microbiol 56:593-597. http://dx.doi.org/10.1099/jmm.0.46964-0.
241. Decre D, Verdet C, Emirian A, Le Gourrierec T, Petit JC, Offenstadt G, Maury E, Brisse S, Arlet G. 2011. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol 49:3012-3014. http://dx.doi.org/10.1128/JCM.00676-11.
242. Evrard B, Balestrino D, Dosgilbert A, Bouya-Gachancard JLJ, Charbonnel N, Forestier C, Tridon A. 2010. Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun 78:210-219. http://dx.doi.org/10.1128/IAI.00864-09.
243. Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Yamaguchi K. 2001. Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection. J Med Microbiol 50:456-461. http://dx.doi.org/10.1099/0022-1317-50-5-456.
244. Regueiro V, Moranta D, Frank CG, Larrarte E, Margareto J, March C, Garmendia J, Bengoechea JA. 2011. Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell Microbiol 13:135-153. http://dx.doi.org/10.1111/j.1462-5822.2010.01526.x.
245. Clements A, Gaboriaud F, Duval JF, Farn JL, Jenney AW, Lithgow T, Wijburg OL, Hartland EL, Strugnell RA. 2008. The major surfaceassociated saccharides of Klebsiella pneumoniae contribute to host cell association. PLoS One 3:e3817. http://dx.doi.org/10.1371/journal.pone.0003817.
246. Simoons-Smit AM, Verweij-Van Vught AM, MacLaren DM. 1986. The role of K antigens as virulence factors in Klebsiella. J Med Microbiol 21:133-137. http://dx.doi.org/10.1099/00222615-21-2-133.
247. Llobet E, Tomas JM, Bengoechea JA. 2008. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154:3877-3886. http://dx.doi.org/10.1099/mic.0.2008/022301-0.
248. Llobet E, Campos MA, Gimenez P, Moranta D, Bengoechea JA. 2011. Analysis of the networks controlling the antimicrobial-peptidedependent induction of Klebsiella pneumoniae virulence factors. Infect Immun 79:3718-3732. http://dx.doi.org/10.1128/IAI.05226-11.
249. Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA. 2012. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and underrecognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31:981-989. http://dx.doi.org/10.1007/s10096-011-1396-6.
250. Yeh KM, Lin JC, Yin FY, Fung CP, Hung HC, Siu LK, Chang FY. 2010. Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation. J Infect Dis 201:1259-1267. http://dx.doi.org/10.1086/606010.
251. Wu JH, Wu AM, Tsai CG, Chang XY, Tsai SF, Wu TS. 2008. Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice. Exp Biol Med (Maywood) 233:64-70. http://dx.doi.org/10.3181/0706-RM-170.
252. Turton JF, Perry C, Elgohari S, Hampton CV. 2010. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol 59:541-547. http://dx.doi.org/10.1099/jmm.0.015198-0.
253. De Majumdar S, Yu J, Fookes M, McAteer SP, Llobet E, Finn S, Spence S, Monaghan A, Kissenpfennig A, Ingram RJ, Bengoechea J, Gally DL, Fanning S, Elborn JS, Schneiders T. 2015. Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation. PLoS Pathog 11:e1004627. http://dx.doi.org/10.1371/journal.ppat.1004627.
254. Frirdich E, Whitfield C. 2005. Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae. J Endotoxin Res 11:133-144. http://dx.doi.org/10.1177/09680519050110030201.
255. Merino S, Altarriba M, Izquierdo L, Nogueras MM, Regue M, Tomas JM. 2000. Cloning and sequencing of the Klebsiella pneumoniae O5 wb gene cluster and its role in pathogenesis. Infect Immun 68:2435-2440. http://dx.doi.org/10.1128/IAI.68.5.2435-2440.2000.
256. Raetz CR, Guan Z, Ingram BO, Six DA, Song F, Wang X, Zhao J. 2009. Discovery of new biosynthetic pathways: the lipid A story. J Lipid Res 50(Suppl):S103-S108. http://dx.doi.org/10.1194/jlr. R800060-JLR200.
257. Hansen DS, Mestre F, Alberti S, Hernandez-Alles S, Alvarez D, Domenech-Sanchez A, Gil J, Merino S, Tomas JM, Benedi VJ. 1999. Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries. J Clin Microbiol 37:56-62.
258. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, Van Der Poll T. 2004. Role of Toll-like receptor 4 in Grampositive and Gram-negative pneumonia in mice. Infect Immun 72:788-794. http://dx.doi.org/10.1128/IAI.72.2.788-794.2004.
259. + Klebsiella pneumoniaeinduced lethal disease by evading Toll-like receptor 4 signaling. Infect Immun 77:615-621. http://dx.doi.org/10.1128/IAI.00931-08.
260. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E. 2006. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7:1066-1073. http://dx.doi.org/10.1038/ni1386.
261. Stead CM, Beasley A, Cotter RJ, Trent MS. 2008. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J Bacteriol 190:7012-7021. http://dx.doi.org/10.1128/JB.00667-08.
262. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. 2009. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol 11:1587-1599. http://dx.doi.org/10.1111/j.1462-5822.2009.01349.x.
263. Llobet E, Martínez-Moliner V, Moranta D, Dahlström KM, Regueiro V, Tomás A, Cano V, Pérez-Gutiérrez C, Frank CG, Fernández-Carrasco H, Insua JL, Salminen TA, Garmendia J, Bengoechea JA. 2 November 2015. Deciphering tissue-induced Klebsiella pneumoniae lipid A structure. Proc Natl Acad Sci U S A http://dx.doi.org/10.1073/pnas.1508820112.
264. Jiang GZ, Sugiyama T, Kato Y, Koide N, Yokochi T. 1995. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect Immun 63:2537-2540.
265. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68:688-693. http://dx.doi.org/10.1128/IAI.68.2.688-693.2000.
266. Shankar-Sinha S, Valencia GA, Janes BK, Rosenberg JK, Whitfield C, Bender RA, Standiford TJ, Younger JG. 2004. The Klebsiella pneumoniaeOantigen contributes to bacteremia and lethality during murine pneumonia. Infect Immun 72:1423-1430. http://dx.doi.org/10.1128/IAI.72.3.1423-1430.2004.
267. Regue M, Hita B, Pique N, Izquierdo L, Merino S, Fresno S, Benedi VJ, Tomas JM. 2004. A gene, uge, is essential for Klebsiella pneumoniae virulence. Infect Immun 72:54-61. http://dx.doi.org/10.1128/IAI.72.1.54-61.2004.
268. Izquierdo L, Coderch N, Pique N, Bedini E, Corsaro MM, Merino S, Fresno S, Tomas JM, Regue M. 2003. The Klebsiella pneumoniae wabG gene: role in biosynthesis of the core lipopolysaccharide and virulence. J Bacteriol 185:7213-7221. http://dx.doi.org/10.1128/JB.185.24.7213-7221.2003.
269. Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini AL. 2014. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 52:2530-2535. http://dx.doi.org/10.1128/JCM.00088-14.
270. Lin WH, Kao CY, Yang DC, Tseng CC, Wu AB, Teng CH, Wang MC, Wu JJ. 2014. Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections. Eur J Clin Microbiol Infect Dis 33:1533-1539. http://dx.doi.org/10.1007/s10096-014-2100-4.
271. Fresno S, Jimenez N, Canals R, Merino S, Corsaro MM, Lanzetta R, Parrilli M, Pieretti G, Regue M, Tomas JM. 2007. A second galacturonic acid transferase is required for core lipopolysaccharide biosynthesis and complete capsule association with the cell surface in Klebsiella pneumoniae. J Bacteriol 189:1128-1137. http://dx.doi.org/10.1128/JB.01489-06.
272. Candan ED, Aksoz N. 2015. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol 62:867-874. http://dx.doi.org/10.18388/abp. 2015-1148.
273. Huynh DT, Kim AY, Seol IH, Jung S, Lim MC, Lee JA, Jo MR, Choi SJ, Kim B, Lee J, Kim W, Kim YR. 2015. Inactivation of the virulence factors from 2, 3-butanediol-producing Klebsiella pneumoniae. Appl Microbiol Biotechnol 99:9427-9438. http://dx.doi.org/10.1007/s00253-015-6861-1.
274. Jung SW, Chae HJ, Park YJ, Yu JK, Kim SY, Lee HK, Lee JH, Kahng JM, Lee SO, Lee MK, Lim JH, Lee CH, Chang SJ, Ahn JY, Lee JW, Park YG. 2013. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol Infect 141:334-340. http://dx.doi.org/10.1017/S0950268812000933.
275. Jung SG, Jang JH, Kim AY, Lim MC, Kim B, Lee J, Kim YR. 2013. Removal of pathogenic factors from 2, 3-butanediol-producing Klebsiella species by inactivating virulence-related wabG gene. Appl Microbiol Biotechnol 97:1997-2007. http://dx.doi.org/10.1007/s00253-012-4284-9.
276. Di Martino P, Livrelli V, Sirot D, Joly B, Darfeuille-Michaud A. 1996. A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 64:2266-2273.
277. Darfeuille-Michaud A, Jallat C, Aubel D, Sirot D, Rich C, Sirot J, Joly B. 1992. R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun 60:44-55.
278. Favre-Bonte S, Darfeuille-Michaud A, Forestier C. 1995. Aggregative adherence of Klebsiella pneumoniae to human intestine-407 cells. Infect Immun 63:1318-1328.
279. Stahlhut SG, Tchesnokova V, Struve C, Weissman SJ, Chattopadhyay S, Yakovenko O, Aprikian P, Sokurenko EV, Krogfelt KA. 2009. Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J Bacteriol 191:6592-6601. http://dx.doi.org/10.1128/JB.00786-09.
280. Klemm P, Schembri MA. 2000. Fimbrial surface display systems in bacteria: from vaccines to random libraries. Microbiology 146(Part 12):3025-3032. http://dx.doi.org/10.1099/00221287-146-12-3025.
281. Gerlach GF, Clegg S, Allen BL. 1989. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 171:1262-1270.
282. Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, Hultgren SJ. 1995. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A 92:2081-2085. http://dx.doi.org/10.1073/pnas.92.6.2081.
283. Rosen DA, Hilliard JK, Tiemann KM, Todd EM, Morley SC, Hunstad DA. 7 September 2015. Klebsiella pneumoniae FimK promotes virulence in murine pneumonia. J Infect Dis http://dx.doi.org/10.1093/infdis/jiv440.
284. Kline KA, Falker S, Dahlberg S, Normark S, Henriques-Normark B. 2009. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 5:580-592. http://dx.doi.org/10.1016/j.chom.2009.05.011.
285. Firon N, Ofek I, Sharon N. 1984. Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria. Infect Immun 43:1088-1090.
286. Tarkkanen AM, Westerlund-Wikstrom B, Erkkila L, Korhonen TK. 1998. Immunohistological localization of the MrkD adhesin in the type 3 fimbriae of Klebsiella pneumoniae. Infect Immun 66:2356-2361.
287. Allen BL, Gerlach GF, Clegg S. 1991. Nucleotide sequence and functions of mrk determinants necessary for expression of type 3 fimbriae in Klebsiella pneumoniae. J Bacteriol 173:916-920.
288. Sebghati TA, Korhonen TK, Hornick DB, Clegg S. 1998. Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun 66:2887-2894.
289. Struve C, Bojer M, Krogfelt KA. 2009. Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun 77:5016-5024. http://dx.doi.org/10.1128/IAI.00585-09.
290. Tarkkanen AM, Virkola R, Clegg S, Korhonen TK. 1997. Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun 65:1546-1549.
291. Wurker M, Beuth J, Ko HL, Przondo-Mordarska A, Pulverer G. 1990. Type of fimbriation determines adherence of Klebsiella bacteria to human epithelial cells. Zentralbl Bakteriol 274:239-245. http://dx.doi.org/10.1016/S0934-8840 (11) 80106-4.
292. Hornick DB, Allen BL, Horn MA, Clegg S. 1992. Adherence to respiratory epithelia by recombinant Escherichia coli expressing Klebsiella pneumoniae type 3 fimbrial gene products. Infect Immun 60:1577-1588.
293. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114-122. http://dx.doi.org/10.1038/nrd1008.
294. Stahlhut SG, Struve C, Krogfelt KA, Reisner A. 2012. Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol 65:350-359. http://dx.doi.org/10.1111/j.1574-695X.2012.00965.x.
295. Schroll C, Barken KB, Krogfelt KA, Struve C. 2010. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol 10:179. http://dx.doi.org/10.1186/1471-2180-10-179.
296. Jagnow J, Clegg S. 2003. Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 149:2397-2405. http://dx.doi.org/10.1099/mic.0.26434-0.
297. Schembri MA, Blom J, Krogfelt KA, Klemm P. 2005. Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun 73:4626-4633. http://dx.doi.org/10.1128/IAI.73.8.4626-4633.2005.
298. Schembri MA, Klemm P. 2001. Biofilm formation in a hydrodynamic environment by novel fimH variants and ramifications for virulence. Infect Immun 69:1322-1328. http://dx.doi.org/10.1128/IAI.69.3.1322-1328.2001.
299. Ramirez P, Bassi GL, Torres A. 2012. Measures to prevent nosocomial infections during mechanical ventilation. Curr Opin Crit Care 18:86-92. http://dx.doi.org/10.1097/MCC.0b013e32834ef3ff.
300. Kollef MH. 2004. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 32:1396-1405. http://dx.doi.org/10.1097/01. CCM.0000128569.09113. FB.
301. Francois P, Vaudaux P, Lew PD. 1998. Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vasc Surg 12:34-40. http://dx.doi.org/10.1007/s100169900112.
302. Murphy CN, Mortensen MS, Krogfelt KA, Clegg S. 2013. Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheterassociated urinary tract infections. Infect Immun 81:3009-3017. http://dx.doi.org/10.1128/IAI.00348-13.
303. Gbarah A, Gahmberg CG, Ofek I, Jacobi U, Sharon N. 1991. Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli. Infect Immun 59:4524-4530.
304. Athamna A, Ofek I. 1988. Enzyme-linked immunosorbent assay for quantitation of attachment and ingestion stages of bacterial phagocytosis. J Clin Microbiol 26:62-66.
305. Malaviya R, Ikeda T, Ross E, Abraham SN. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80. http://dx.doi.org/10.1038/381077a0.
306. Przondo-Mordarska A, Ko HL, Beuth J, Gamian A, Pulverer G. 1991. Chemiluminescence response of human polymorphonuclear leukocytes induced by purified, latex attached Klebsiella fimbriae. Zentralbl Bakteriol 275:521-529. http://dx.doi.org/10.1016/S0934-8840 (11) 80174-X.
307. Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, Hasty D, Kekow J, Ullmann U, Ofek I, Sela S. 2000. Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae. Infect Immun 68:6744-6749. http://dx.doi.org/10.1128/IAI.68.12.6744-6749.2000.
308. Favre-Bonte S, Joly B, Forestier C. 1999. Consequences of reduction of Klebsiella pneumoniae capsule expression on interactions of this bacterium with epithelial cells. Infect Immun 67:554-561.
309. Bullen JJ, Rogers HJ, Griffiths E. 1972. Iron binding proteins and infection. Br J Haematol 23:389-392. http://dx.doi.org/10.1111/j.1365-2141.1972.tb07073.x.
310. Carniel E. 2001. The Yersinia high-pathogenicity island: an iron-uptake island. Microbes Infect 3:561-569. http://dx.doi.org/10.1016/S1286-4579 (01) 01412-5.
311. Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413-451. http://dx.doi.org/10.1128/MMBR.00012-07.
312. Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN. 2012. Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio 3:e00224-11. http://dx.doi.org/10.1128/mBio.00224-11.
313. Brock JH, Williams PH, Liceaga J, Wooldridge KG. 1991. Relative availability of transferrin-bound iron and cell-derived iron to aerobactinproducing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect Immun 59:3185-3190.
314. Perry RD, Balbo PB, Jones HA, Fetherston JD, DeMoll E. 1999. Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology 145(Part 5):1181-1190.
315. Podschun R, Sievers D, Fischer A, Ullmann U. 1993. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 168:1415-1421. http://dx.doi.org/10.1093/infdis/168.6.1415.
316. Tarkkanen AM, Allen BL, Williams PH, Kauppi M, Haahtela K, Siitonen A, Orskov I, Orskov F, Clegg S, Korhonen TK. 1992. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 60:1187-1192.
317. Koczura R, Kaznowski A. 2003. Occurrence of the Yersinia highpathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae. Microb Pathog 35:197-202. http://dx.doi.org/10.1016/S0882-4010 (03) 00125-6.
318. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R. 2013. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris) 61:209-216. http://dx.doi.org/10.1016/j.patbio.2012.10.004.
319. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT. 2008. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 197:1717-1727. http://dx.doi.org/10.1086/588383.
320. Müller S, Valdebenito M, Hantke K. 2009. Salmochelin, the longoverlooked catecholate siderophore of Salmonella. Biometals 22:691-695. http://dx.doi.org/10.1007/s10534-009-9217-4.
321. Lawlor MS, O'Connor C, Miller VL. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75:1463-1472. http://dx.doi.org/10.1128/IAI.00372-06.
322. Lai YC, Peng HL, Chang HY. 2001. Identification of genes induced in vivo during Klebsiella pneumoniae CG43 infection. Infect Immun 69:7140-7145. http://dx.doi.org/10.1128/IAI.69.11.7140-7145.2001.
323. Cowland JB, Borregaard N. 1997. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45:17-23. http://dx.doi.org/10.1006/geno. 1997.4896.
324. Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK. 2009. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182:4947-4956. http://dx.doi.org/10.4049/jimmunol.0803282.
325. Nelson AL, Barasch JM, Bunte RM, Weiser JN. 2005. Bacterial colonization of nasal mucosa induces expression of siderocalin, an ironsequestering component of innate immunity. Cell Microbiol 7:1404-1417. http://dx.doi.org/10.1111/j.1462-5822.2005.00566.x.
326. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10:1033-1043. http://dx.doi.org/10.1016/S1097-2765 (02) 00708-6.
327. Bachman MA, Miller VL, Weiser JN. 2009. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 5:e1000622. http://dx.doi.org/10.1371/journal.ppat.1000622.
328. Wasserman SI, Soter NA, Center DM, Austen KF. 1977. Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60:189-196.
329. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, Dozois CM, Weiser JN. 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79:3309-3316. http://dx.doi.org/10.1128/IAI.05114-11.
330. Bach S, De Almeida A, Carniel E. 2000. The Yersinia high-pathogenicity island is present in different members of the family Enterobacteriaceae. FEMS Microbiol Lett 183:289-294. http://dx.doi.org/10.1111/j.1574-6968.2000.tb08973.x.
331. Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA. 8 June 2015. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect Immun http://dx.doi.org/10.1128/IAI.00430-15.
332. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD. 2006. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A 103:16502-16507. http://dx.doi.org/10.1073/pnas.0604636103.
333. Fischbach MA, Lin H, Liu DR, Walsh CT. 2005. In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc Natl Acad Sci U S A 102:571-576. http://dx.doi.org/10.1073/pnas.0408463102.
334. Hantke K, Nicholson G, Rabsch W, Winkelmann G. 2003. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A 100:3677-3682. http://dx.doi.org/10.1073/pnas.0737682100.
335. Vernet V, Philippon A, Madoulet C, Vistelle R, Jaussaud R, Chippaux C. 1995. Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumoniae and Escherichia coli blood culture isolates. FEMS Microbiol Lett 130:51-57. http://dx.doi.org/10.1111/j.1574-6968.1995.tb07697.x.
336. Nassif X, Sansonetti PJ. 1986. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 54:603-608.
337. Chen YT, Chang HY, Lai YC, Pan CC, Tsai SF, Peng HL. 2004. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337:189-198. http://dx.doi.org/10.1016/j.gene.2004.05.008.
338. Tang HL, Chiang MK, Liou WJ, Chen YT, Peng HL, Chiou CS, Liu KS, Lu MC, Tung KC, Lai YC. 2010. Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur J Clin Microbiol Infect Dis 29:689-698. http://dx.doi.org/10.1007/s10096-010-0915-1.
339. Hsieh PF, Liu JY, Pan YJ, Wu MC, Lin TL, Huang YT, Wang JT. 2013. Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation. J Infect Dis 208:1580-1589. http://dx.doi.org/10.1093/infdis/jit384.
340. Pichavant M, Delneste Y, Jeannin P, Fourneau C, Brichet A, Tonnel AB, Gosset P. 2003. Outer membrane protein A from Klebsiella pneumoniae activates bronchial epithelial cells: implication in neutrophil recruitment. J Immunol 171:6697-6705. http://dx.doi.org/10.4049/jimmunol.171.12.6697.
341. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, Maina V, Magistrelli G, Haeuw JF, Hoeffel G, Thieblemont N, Corvaia N, Garlanda C, Delneste Y, Mantovani A. 2005. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551-560. http://dx.doi.org/10.1016/j.immuni.2005.03.008.
342. Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, Bonnefoy JY, Delneste Y. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20(Suppl 4):A23-A27. http://dx.doi.org/10.1016/S0264-410X (02) 00383-3.
343. Llobet E, March C, Gimenez P, Bengoechea JA. 2009. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob Agents Chemother 53:298-302. http://dx.doi.org/10.1128/AAC.00657-08.
344. March C, Moranta D, Regueiro V, Llobet E, Tomas A, Garmendia J, Bengoechea JA. 2011. Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem 286:9956-9967. http://dx.doi.org/10.1074/jbc. M110.181008.
345. Chen JH, Siu LK, Fung CP, Lin JC, Yeh KM, Chen TL, Tsai YK, Chang FY. 2010. Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 65:986-990. http://dx.doi.org/10.1093/jac/dkq056.
346. Shin SY, Bae IK, Kim J, Jeong SH, Yong D, Kim JM, Lee K. 2012. Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. JMedMicrobiol 61:239-245. http://dx.doi.org/10.1099/jmm.0.037036-0.
347. Hernandez-Alles S, Alberti S, Alvarez D, Domenech-Sanchez A, Martinez-Martinez L, Gil J, Tomas JM, Benedi VJ. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145(Part 3):673-679.
348. Garcia-Fernandez A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, Carattoli A. 2010. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 54:4178-4184. http://dx.doi.org/10.1128/AAC.01301-09.
349. Chudackova E, Bergerova T, Fajfrlik K, Cervena D, Urbaskova P, Empel J, Gniadkowski M, Hrabak J. 2010. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 betalactamases in a Czech hospital. FEMS Microbiol Lett 309:62-70. http://dx.doi.org/10.1111/j.1574-6968.2010.02016.x.
350. Mena A, Plasencia V, Garcia L, Hidalgo O, Ayestaran JI, Alberti S, Borrell N, Perez JL, Oliver A. 2006. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44:2831-2837. http://dx.doi.org/10.1128/JCM.00418-06.
351. Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659-667. http://dx.doi.org/10.1093/jac/dkp029.
352. Hernandez-Alles S, Conejo M, Pascual A, Tomas JM, Benedi VJ, Martinez-Martinez L. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 46:273-277. http://dx.doi.org/10.1093/jac/46.2.273.
353. Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY, Chen TL, Siu LK. 2011. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55:1485-1493. http://dx.doi.org/10.1128/AAC.01275-10.
354. March C, Cano V, Moranta D, Llobet E, Perez-Gutierrez C, Tomas JM, Suarez T, Garmendia J, Bengoechea JA. 2013. Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PLoS One 8:e56847. http://dx.doi.org/10.1371/journal.pone.0056847.
355. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea JA, Alberti S. 2010. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54:177-183. http://dx.doi.org/10.1128/AAC.00715-09.
356. Wang X, Chen H, Zhang Y, Wang Q, Zhao C, Li H, He W, Zhang F, Wang Z, Li S, Wang H. 2015. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: role of the global regulator RamA and its local repressor RamR. Int J Antimicrob Agents 45:635-640. http://dx.doi.org/10.1016/j.ijantimicag.2014.12.022.
357. Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH. 2015. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 70:81-88. http://dx.doi.org/10.1093/jac/dku340.
358. Zhong X, Xu H, Chen D, Zhou H, Hu X, Cheng G. 2014. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PLoS One 9:e115185. http://dx.doi.org/10.1371/journal.pone.0115185.
359. Ma LC, Fang CT, Lee CZ, Shun CT, Wang JT. 2005. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis 192:117-128. http://dx.doi.org/10.1086/430619.
360. Vogels GD, Van Der Drift C. 1976. Degradation of purines and pyrimidines by microorganisms. Bacteriol Rev 40:403-468.
361. Chou HC, Lee CZ, Ma LC, Fang CT, Chang SC, Wang JT. 2004. Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun 72:3783-3792. http://dx.doi.org/10.1128/IAI.72.7.3783-3792.2004.
362. Compain F, Babosan A, Brisse S, Genel N, Audo J, Ailloud F, Kassis-Chikhani N, Arlet G, Decre D. 2014. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J Clin Microbiol 52:4377-4380. http://dx.doi.org/10.1128/JCM.02316-14.
363. Bachman MA, Breen P, Deornellas V, Mu Q, Zhao L, Wu W, Cavalcoli JD, Mobley HLT. 2015. Genome-wide identification of Klebsiella pneumoniae fitness genes during lung infection. mBio 6:e00775-15. http://dx.doi.org/10.1128/mBio.00775-15.
364. Maroncle N, Balestrino D, Rich C, Forestier C. 2002. Identification of Klebsiella pneumoniae genes involved in intestinal colonization and adhesion using signature-tagged mutagenesis. Infect Immun 70:4729-4734. http://dx.doi.org/10.1128/IAI.70.8.4729-4734.2002.
365. Struve C, Forestier C, Krogfelt KA. 2003. Application of a novel multiscreening signature-tagged mutagenesis assay for identification of Klebsiella pneumoniae genes essential in colonization and infection. Microbiology 149:167-176. http://dx.doi.org/10.1099/mic.0.25833-0.
366. Tu YC, Lu MC, Chiang MK, Huang SP, Peng HL, Chang HY, Jan MS, Lai YC. 2009. Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun 77:2657-2671. http://dx.doi.org/10.1128/IAI.01523-08.
367. Lery LM, Frangeul L, Tomas A, Passet V, Almeida AS, Bialek-Davenet S, Barbe V, Bengoechea JA, Sansonetti P, Brisse S, Tournebize R. 2014. Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biol 12:41. http://dx.doi.org/10.1186/1741-7007-12-41.
368. Tomas A, Lery L, Regueiro V, Perez-Gutierrez C, Martinez V, Moranta D, Llobet E, Gonzalez-Nicolau M, Insua JL, Tomas JM, Sansonetti PJ, Tournebize R, Bengoechea JA. 13 May 2015. Functional genomic screen identifies Klebsiella pneumoniae factors implicated in blocking NF-kappaB signalling. J Biol Chem http://dx.doi.org/10.1074/jbc. M114.621292.
369. Lavender HF, Jagnow JR, Clegg S. 2004. Biofilm formation in vitro and virulence in vivo of mutants of Klebsiella pneumoniae. Infect Immun 72:4888-4890. http://dx.doi.org/10.1128/IAI.72.8.4888-4890.2004.
370. Boddicker JD, Anderson RA, Jagnow J, Clegg S. 2006. Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material. Infect Immun 74:4590-4597. http://dx.doi.org/10.1128/IAI.00129-06.
371. Wu MC, Lin TL, Hsieh PF, Yang HC, Wang JT. 2011. Isolation of genes involved in biofilm formation of a Klebsiella pneumoniae strain causing pyogenic liver abscess. PLoS One 6:e23500. http://dx.doi.org/10.1371/journal.pone.0023500.
372. Nassif X, Fournier JM, Arondel J, Sansonetti PJ. 1989. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 57:546-552.
373. Frank CG, Reguerio V, Rother M, Moranta D, Maeurer AP, Garmendia J, Meyer TF, Bengoechea JA. 2013. Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell Microbiol 15:1212-1233. http://dx.doi.org/10.1111/cmi.12110.
374. Maroncle N, Rich C, Forestier C. 2006. The role of Klebsiella pneumoniae urease in intestinal colonization and resistance to gastrointestinal stress. Res Microbiol 157:184-193. http://dx.doi.org/10.1016/j.resmic.2005.06.006.
375. Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, Von Gottberg A, Goossens H, Wagener MM, Benedi VJ. 2007. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis 13:986-993. http://dx.doi.org/10.3201/eid1307.070187.